Article Details
Retrieved on: 2024-02-19 17:09:54
Tags for this article:
Click the tags to see associated articles and topics
Summary
The University of Nebraska-Lincoln researchers, Janos Zempleni and Jiantao Guo, won an NIH award for developing milk exosomes as a biotechnology platform to deliver CRISPR-Cas9 genome editors for treating various diseases. Their work brings together genetic engineering, molecular biology, and advances in exosome technology for gene therapy applications.
Article found on: www.news-medical.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here